Bank of New York Mellon’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-149,355
Closed -$261K 4246
2025
Q1
$261K Hold
149,355
﹤0.01% 3766
2024
Q4
$236K Sell
149,355
-1
-0% -$2 ﹤0.01% 3887
2024
Q3
$234K Sell
149,356
-47,837
-24% -$79.1K ﹤0.01% 3864
2024
Q2
$352K Buy
+197,193
New +$458K ﹤0.01% 3744
2019
Q1
Sell
-2,730
Closed -$25K 4241
2018
Q4
$25K Buy
2,730
+2,445
+858% +$40.5K ﹤0.01% 4136
2018
Q3
$7K Hold
285
﹤0.01% 4233
2018
Q2
$23K Sell
285
-277
-49% -$22.9K ﹤0.01% 4161
2018
Q1
$49K Buy
562
+256
+84% +$34.3K ﹤0.01% 4173
2017
Q4
$39K Buy
306
+21
+7% +$2.66K ﹤0.01% 4233
2017
Q3
$43K Buy
285
+81
+40% +$10.2K ﹤0.01% 4130
2017
Q2
$24K Sell
204
-766
-79% -$128K ﹤0.01% 4215
2017
Q1
$192K Sell
970
-140
-13% -$26.6K ﹤0.01% 3894
2016
Q4
$299K Sell
1,110
-30
-3% -$9.75K ﹤0.01% 3784
2016
Q3
$452K Sell
1,140
-37
-3% -$15.2K ﹤0.01% 3591
2016
Q2
$408K Buy
1,177
+168
+17% +$120K ﹤0.01% 3621
2016
Q1
$839K Sell
1,009
-71
-7% -$56.5K ﹤0.01% 3170
2015
Q4
$1.13M Buy
1,080
+102
+10% +$102K ﹤0.01% 3090
2015
Q3
$767K Sell
978
-195
-17% -$200K ﹤0.01% 3344
2015
Q2
$1.54M Buy
1,173
+562
+92% +$907K ﹤0.01% 3078
2015
Q1
$1.24M Buy
611
+3
+0.5% +$6.52K ﹤0.01% 3175
2014
Q4
$1.17M Buy
608
+80
+15% +$142K ﹤0.01% 3214
2014
Q3
$433K Hold
528
﹤0.01% 3684
2014
Q2
$509K Buy
528
+40
+8% +$34.3K ﹤0.01% 3600
2014
Q1
$529K Sell
488
-5
-1% -$5.54K ﹤0.01% 3570
2013
Q4
$437K Buy
493
+12
+2% +$10.3K ﹤0.01% 3626
2013
Q3
$544K Sell
481
-1
-0.2% -$1.18K ﹤0.01% 3488
2013
Q2
$568K Buy
+482
New +$458K ﹤0.01% 3445

Other funds holding RGLS